Divi’s Laboratories concludes inspection at Visakhapatnam facility with no critical observations

04 Aug 2017 Evaluate

Divi’s Laboratories has successfully completed inspection carried out by 5 inspectors from HRPA (Ireland) and JAZMP (Slovenia) at its Unit-2 Visakhapatnam facility with no critical observations. The inspection was carried out between July 31, 2017 and August 4, 2017.

The inspection was focused on follow up on the effectiveness of the CAPA’s implemented from the last JAZMP inspection and general GMP inspection of the site.

Divi’s Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

3918.75 6.85 (0.18%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.